Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkins lymphoma in the elderly. With the rising proportion of older persons in India, it is important to study current patterns and management of this disease, given that data in this regard are scarce in Indian settings....
Main Authors: | K N Lokesh, M C. Suresh Babu, K C Lakshmaiah, K Govind Babu, Smitha C Saldanha, D Loknatha, Linu Abraham Jacob, S Vishwanath, C S Premalatha, P R Kiran |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
Series: | South Asian Journal of Cancer |
Subjects: | |
Online Access: | http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=72;epage=74;aulast=Lokesh |
Similar Items
-
Primary Central Nervous System Lymphoma: An Experience of a Regional Cancer Center from India
by: Budhi Singh Yadav, et al.
Published: (2019-01-01) -
Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma
by: K. Lisenko, et al.
Published: (2017-05-01) -
Dual-Positive (CD4+/CD8+) Acute Adult T-Cell Leukemia/Lymphoma Associated with Complex Karyotype and Refractory Hypercalcemia: Case Report and Literature Review
by: Shahzad Raza, et al.
Published: (2010-12-01) -
Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
by: Sung Yong Oh, et al.
Published: (2019-10-01) -
Silencing aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway
by: Shaoxiong Wang, et al.
Published: (2021-09-01)